Paushak is the largest manufacturer of phosgene-based specialty chemicals in India. One of the key reasons for being constructive on the stock is the regulatory permission to expand its production capacity of 4,800 tonne by 3 times.
The Rs 120-crore capex project is expected to be fully operational by fiscal 2023 with a payback period of about 5 years.
In the special segment ‘Moneycontrol Pro Ideas For Profit’, Moneycontrol.com’s Anubhav Sahu gets more details on the stock’s performance going forward.
Watch video for more